12/15/11: Ben Philpot and Mark Zylka received a dual-PI RO1 January 10, 2012 By Nathaniel Bailey Faculty members Ben Philpot and Mark Zylka received a dual-PI R01 grant from the National Institute of Mental Health (NIMH) to study drugs that regulate expression of Ube3a, a ubiquitin protein ligase that is mutated in Angelman syndrome Filed Under: Categories: News More from UNC Neuroscience Center Researchers Wrestle with Accuracy of AI Technology Used to Create New Drug Candidates Scientists Discover Surprising Details about Xylazine in Combination with Fentanyl Researchers Discover How We Perceive Bitter Taste